
iTeos Therapeutics ITOS
Quarterly report 2025-Q2
added 08-06-2025
iTeos Therapeutics ROE Ratio 2011-2026 | ITOS
Annual ROE Ratio iTeos Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.77 | -19.58 | 14.57 | 38.8 | -11.77 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.8 | -22.77 | -0.15 |
Quarterly ROE Ratio iTeos Therapeutics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.45 | -21.58 | -15.32 | -20.7 | -18.91 | -23.34 | -13.27 | -13.12 | -7.57 | -1.19 | 12.15 | 30.87 | 49.43 | 39.41 | 5.25 | 1.95 | -20.08 | -13.17 | -7.16 | 12.02 | 34.5 | 52.68 | 62.92 | 62.92 | 43.74 | 27.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62.92 | -36.45 | 8.61 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
-15.14 | $ 3.52 | -1.26 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-28.74 | $ 3.22 | 2.88 % | $ 229 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | ||
|
Aptorum Group Limited
APM
|
-20.19 | $ 0.8 | 1.81 % | $ 4.36 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-138.5 | $ 4.13 | -1.67 % | $ 105 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.4 | -5.82 % | $ 8.18 B | ||
|
Ascendis Pharma A/S
ASND
|
-43.41 | $ 228.5 | -1.09 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-57.49 | $ 6.1 | 0.83 % | $ 497 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-30.74 | $ 6.6 | -0.45 % | $ 181 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Anika Therapeutics
ANIK
|
-38.95 | $ 14.52 | 1.11 % | $ 213 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
BioCardia
BCDA
|
721.83 | $ 1.3 | 2.36 % | $ 27.5 M | ||
|
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-116.29 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-71.51 | $ 2.67 | 1.14 % | $ 16.8 M | ||
|
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.49 | -1.32 % | $ 380 M | ||
|
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
1.11 | $ 92.62 | 2.3 % | $ 27.2 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 8.28 | 2.73 % | $ 1.35 B | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
-116.74 | $ 1.16 | 4.5 % | $ 34.9 M |